Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 20 stocks, with a combined market cap of $3.02 trillion, total revenue of $684.11 billion and a weighted average PE ratio of 29.67.

Market Cap
3.02T
Revenue
684.11B
Profits
101.81B
PE Ratio
29.67
Profit Margin
14.88%
Dividend Yield
2.30%

19 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company680.28B0.43%1,516,87745.04B
2JNJJohnson & Johnson370.49B-0.40%7,261,67989.33B
3ABBVAbbVie Inc.314.10B-0.86%5,211,29056.33B
4NVONovo Nordisk A/S294.67B-2.76%4,712,29540.31B
5AZNAstraZeneca PLC210.97B-0.21%3,780,45254.07B
6NVSNovartis AG209.02B0.42%1,282,31051.72B
7MRKMerck & Co., Inc.196.78B-1.23%9,310,40864.17B
8AMGNAmgen Inc.159.11B0.68%1,595,77633.42B
9GILDGilead Sciences, Inc.131.89B-0.66%5,085,08128.75B
10PFEPfizer Inc.127.38B1.54%40,282,85863.63B
11SNYSanofi126.91B-1.85%3,719,84945.85B
12BMYBristol-Myers Squibb Company101.51B-2.82%9,895,50448.30B
13GSKGSK plc70.71B1.18%2,695,34039.28B
14BIIBBiogen Inc.17.19B-1.51%555,8369.68B
15GRFSGrifols, S.A.5.80B1.50%575,6137.47B
16OGNOrganon & Co.2.86B-1.86%2,007,6376.40B
17AMRNAmarin Corporation plc200.88M2.43%143,871228.61M
18SCLXScilex Holding Company33.72M-2.39%158,34156.59M
19MIRAMIRA Pharmaceuticals, Inc.14.97M0.01%32,970-